What are the reporting requirements for the JW modifier in OPPS hospitals when billing for discarded drugs?
Reporting of the JW modifier is required as of January 1, 2017. When reporting both the administered volume of a drug as well as the discarded amount of a drug prepared from a single-dose vial or single-use package, providers are instructed to document the discarded drug or biological in the patient’s medical record. For OPPS hospitals, reporting this modifier is required for all separately payable drugs assigned status indicators G (Pass-through Drugs and Biologicals) or K (Nonpass-through Drugs and Nonimplantable Biologicals, including Therapeutic Radiopharmaceuticals) when an unused or discarded amount is documented and submitted for reimbursement.
This question was answered in our Coding Essentials for Infusion & Injection Therapy Services. For more hot topics relating to infusion services, please visit our store or call us at 1.800.252.1578, ext. 2.
CPT® copyright 2025 American Medical Association (AMA). All rights reserved.
Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
CPT is a registered trademark of the American Medical Association.
Celebrate Lab Week with MedLearn! Sign up to win one year of our Laboratory All Access Pass! Click here to learn more →
BLOOM INTO SAVINGS! Get 25% OFF during our spring sale through March 27. Use code SPRING26 at checkout to claim this offer.
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 1 with code CYBER25
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24